Intravenous high dose glucocorticoids in patients with ankylosing spondylitis

Terapevticheskii Arkhiv

Volumn 78, Issue 12, 2006, Pages 71-75

  Rumyantseva, O A ^a   Bochkova, A G ^a   Loginova, E Yu ^a   Kiseleva, N M ^a   Pushkova, O V ^a   Bunchuk, N V ^a  

^a NONE

Author keywords

Ankylosing spondilitis; Bekhterev's disease; Glucocorticoids; Pulse therapy with glucocorticoids

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; METHYLPREDNISOLONE SODIUM SUCCINATE;

ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE HEMISUCCINATE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 33846563861     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mintz G., Enriquez R. D., Mercado U., Robles E. J. et al. Intravenous methyl-prednisolone pulse therapy in severe ankylosing spondylitis. Arthr. and Rheum. 1981; 24 (5): 734-736.
2. Ejstrup L., Peters N. D. Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Dan. Med. Bull. 1985; 32 (4): 231-233.
3. Russian source
4. Peters N. D., Ejstrup L. Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Scand. J. Rheumatol. 1992; 21(3): 134-138.
5. Van der Linden S., Valkenburg H. A., Cats A. Modified New York criteria 1984. (Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria). Arthr. and Rheum. 1984; 27: 361-368.
6. Garrett S., Jenkinson T., Kennedy L. G. et al. A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index. J. Rheumatol. 1994; 21 (12): 2286-2291.
7. Calin A., Garrett S., Whitelock H. et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index. J. Rheumatol. 1994; 21 (12): 2281-2285.
8. Anderson J. J., Baron G., van der Heijde D. et al. Ankylosing spondylitis assessment group preliminary definition of short-trem improvement in ankylosing spondylitis. Arthr. and Rheum. 2001; 44: 1876-1886.
9. Nasswetter G., Pineiro D. J., Garcia Morteo O. M. et al. Holter monitoring in ankylosing spondylitis patients during methylprednisolone pulse therapy. Clin. Rheumatol. 1984; 3 (1): 29-31.
10. Braun J., Brandt J., Listing J. et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002; 359 (9313): 1187-1193.